BMS could soon face competition in the HCM space as Cytokinetics awaits a marketing application decision from the FDA for ...

Australia-based Neuren Pharmaceuticals has confirmed the primary goals for its double-blind, single Phase III pivotal trial ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...

Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its ...

Following a recent Type D meeting with the FDA, a phase 3 clinical trial design for darovasertib in primary uveal melanoma ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

An add-on agent designed to boost drugs that treat age-related macular degeneration failed to show any benefit in two phase 3 ...

Initial results from the ongoing trial saw one patient achieving a complete response in the trial combining Tovecimig with ...

Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

Opthea’s staff are paying for its clinical failures. Days after back-to-back flops sank an eye disease asset, the biotech ...